Schroder Investment Management Group Sage Therapeutics, Inc. Transaction History

Schroder Investment Management Group

$83.3 Billion
Q1 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$16.75 - $48.98 $1.65 Million - $4.81 Million	-98,228 Reduced 65.35%	52,076 $1.07 Million
Q2 2023 Aug 11, 2023	BUY	$40.65 - $59.54 $3.92 Million - $5.74 Million	96,378 Added 178.72%	150,304 $7.07 Million
Q1 2023 May 11, 2023	SELL	$37.27 - $46.57 $128,954 - $161,132	-3,460 Reduced 6.03%	53,926 $2.26 Million
Q4 2022 Feb 10, 2023	BUY	$32.2 - $43.61 $1.85 Million - $2.5 Million	57,386 New	57,386 $2.19 Million
Q1 2022 May 16, 2022	SELL	$30.71 - $45.71 $4,391 - $6,536	-143 Closed	0 $0

Q4 2021 Feb 14, 2022	BUY	$37.06 - $47.11 $2,186 - $2,779	59 Added 70.24%	143 $6,000
Q2 2021 Aug 13, 2021	SELL	$54.88 - $79.29 $1.66 Million - $2.4 Million	-30,315 Reduced 99.72%	84 $5,000
Q1 2021 May 17, 2021	SELL	$70.65 - $96.76 $3.6 Million - $4.94 Million	-51,016 Reduced 62.66%	30,399 $2.28 Million
Q4 2020 Feb 16, 2021	BUY	$58.41 - $89.06 $365,120 - $556,714	6,251 Added 8.32%	81,415 $7.04 Million
Q3 2020 Nov 13, 2020	BUY	$41.13 - $62.45 $600,950 - $912,456	14,611 Added 24.13%	75,164 $4.39 Million
Q2 2020 Aug 13, 2020	BUY	$25.95 - $43.15 $1.01 Million - $1.68 Million	39,045 Added 181.54%	60,553 $2.52 Million
Q1 2020 May 15, 2020	BUY	$26.15 - $77.24 $562,434 - $1.66 Million	21,508 New	21,508 $610,000
Q4 2019 Feb 11, 2020	SELL	$60.18 - $154.77 $74,563 - $191,760	-1,239 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$140.29 - $189.96 $56,396 - $76,363	402 Added 48.03%	1,239 $177,000
Q2 2019 Aug 08, 2019	SELL	$157.85 - $183.09 $186,736 - $216,595	-1,183 Reduced 58.56%	837 $153,000
Q1 2019 May 14, 2019	SELL	$89.33 - $163.65 $56,277 - $103,099	-630 Reduced 23.77%	2,020 $321,000
Q4 2018 Feb 14, 2019	SELL	$81.94 - $139.71 $12,372 - $21,096	-151 Reduced 5.39%	2,650 $254,000
Q3 2018 Nov 13, 2018	BUY	$138.11 - $169.04 $58,834 - $72,011	426 Added 17.94%	2,801 $396,000
Q2 2018 Aug 13, 2018	BUY	$140.36 - $175.76 $333,355 - $417,430	2,375 New	2,375 $361,000

Others Institutions Holding SAGE

# of Institutions

220

Shares Held

52.7M

Call Options Held

207K

Put Options Held

191K

Vanguard Group Inc Valley Forge, PA

5.75M
Shares

$70.7 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

5.48M
Shares

$67.4 Million
1.65% of portfolio
Black Rock Inc. New York, NY

4.89M
Shares

$60.1 Million
0.0% of portfolio
Wellington Management Group LLP Boston, MA

4.75M
Shares

$58.4 Million
0.02% of portfolio
State Street Corp Boston, MA

4.49M
Shares

$55.2 Million
0.0% of portfolio

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $730M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Account